Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...
Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...
Senior Manufacturing Science Associate Diane Morgan performs an analysis of plasmid DNA at Vernal Biosciences in Colchester on Tuesday, Aug. 12. Photo by Glenn Russell/VTDigger U.S. Health and Human ...
When Lyme disease makes the news, it's typically not for positive reasons — but Pfizer is gearing up to seek regulatory ...
Bacterial ghosts (BGs) represent an innovative platform that exploits empty Gram‐negative bacterial envelopes produced through controlled lysis. These envelopes retain the native antigenic ...
The Food and Drug Administration’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory processes. The first sign of trouble was the ...
India, March 19 -- A room-temperature vaccine could help prevent massive vaccine wastage by staying effective without ...
Until May, the Duke Consortia for HIV/AIDS Vaccine Development (CHAVD) had conducted its groundbreaking research with federal funding. Then the National Institutes of Health terminated the program, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results